About this item:

520 Views | 300 Downloads

Author Notes:

Corresponding Author: Daniel J. Brat, M.D., Ph.D., Department of Pathology and Laboratory Medicine, Emory University Hospital, G-167, 1364 Clifton Road NE, Atlanta, GA 30322, Phone: 404-712-1266, Fax: 404-727-3133, dbrat@emory.edu.

The authors would like to thank the Research Pathology Lab of the Cancer Tissue and Pathology Shared Resource within the Winship Cancer Institute for their assistance with whole slide scanning and digital pathology, especially Candace Chisolm.

The authors would also like to thank the leadership and support staff of the TCGA Working Group and Expert Pathology Committee for their assistance in the generation of publicly available data.

The authors have no conflicts of interest.

Subjects:

Research Funding:

This work was supported by US Public Health Service grants from the Clinical and Translational Science Award program, NIH, NCRR UL RR025008, TL1 RR025010; the In Silico Center for Brain Tumor Research Contract ST12-1100 (NCI-SAIC Frederick); and the Winship Cancer Center Support Grant (P30 CA138292).

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Oncology
  • REGULATORY T-CELLS
  • COLORECTAL-CANCER
  • PROGNOSTIC VALUE
  • SURVIVAL
  • GLIOMA
  • EXPRESSION
  • IDH1
  • IMMUNOTHERAPY
  • ASTROCYTOMAS
  • COMPARTMENT

Tumor-Infiltrating Lymphocytes in Glioblastoma Are Associated with Specific Genomic Alterations and Related to Transcriptional Class

Show all authors Show less authors

Tools:

Journal Title:

Clinical Cancer Research

Volume:

Volume 19, Number 18

Publisher:

, Pages 4951-4960

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Purpose: Tumor-infiltrating lymphocytes (TIL) have prognostic significance in many cancers, yet their roles in glioblastoma have not been fully defined. We hypothesized that TILs in glioblastoma are associated with molecular alterations, histologies, and survival. Experimental Design: We used data from The Cancer Genome Atlas (TCGA) to investigate molecular, histologic, and clinical correlates of TILs in glioblastomas. Lymphocytes were categorized as absent, present, or abundant in histopathologic images from 171 TCGA glioblastomas. Associations were examined between lymphocytes and histologic features, mutations, copy number alterations, CpG island methylator phenotype, transcriptional class, and survival. Wevalidated histologic findings usingCD3Ggene expression. Results: Wefound a positive correlation between TILs and glioblastomas with gemistocytes, sarcomatous cells, epithelioid cells, and giant cells. Lymphocytes were enriched in the mesenchymal transcriptional class and strongly associated with mutations in NF1 and RB1. These mutations are frequent in the mesenchymal class and characteristic of gemistocytic, sarcomatous, epithelioid, and giant cell histologies. Conversely, TILs were rare in glioblastomas with small cells and oligodendroglioma components. Lymphocytes were depleted in the classical transcriptional class and in EGF receptor (EGFR)-amplified and homozygous PTEN-deleted glioblastomas. These alterations are characteristic of glioblastomas with small cells and glioblastomas of the classical transcriptional class. No association with survival was shown. Conclusions: TILs were enriched in glioblastomas of the mesenchymal class, strongly associated with mutations in NF1 and RB1 and typical of histologies characterized by these mutations. Conversely, TILs were depleted in the classical class, EGFR-amplified, and homozygous PTEN-deleted tumors and rare in histologies characterized by these alterations.

Copyright information:

© 2013 American Association for Cancer Research.

Export to EndNote